What's this? This is an unbiased just-the-facts news timeline ('newsline') about Announcement, created by Newslines contributors. Become a contributor

Announcement

Biography view > Click for Latest News view
6 Feb, 1958

Air Disaster

0 Comments

_39657335_crash238borderSeven Manchester United footballers are among 21 dead after an air crash in Munich. The British European Airways (BEA) plane caught fire shortly after take off this afternoon with 38 passengers and six crew on board.

 

12 Jul, 1974

Quits Liverpool

0 Comments

_38586127_shankly_1974_238The manager of Liverpool football club is retires from his postShankly, 58, has been in charge at Anfield for nearly 15 years. He made the decision to leave five weeks ago, but club directors have been trying to persuade him to stay.

18 Aug, 1989

Record takeover deal

0 Comments

The Club is sold for £20m in the biggest takeover deal in the history of British football. The new owner is Isle of Man-based property tycoon and former footballer, Michael Knighton. Manchester United chairman Martin Edwards is to receive more than £10m for his majority share in the club and will stay on as chief executive. There had been rumours for some time that Mr Edwards was planning to sell his stake but the deal was shrouded in secrecy.

Oct 1993

Forcasts Technotribalism

0 Comments

Celente issues a press release stating social media and the internet will be on the rise in coming years, and consumers of it will “think globally” but act locally and become more isolated.

The techno-tribalism trend will echo the sentiment of the new, growing isolation trend. People, concerned about their own welfare, are increasingly embracing a view that they shouldn’t have to solve other regions crises.

20 Mar, 2000

$60m Kozmo.com investment

0 Comments

Kozmo LogoAmazon invests sixty million dollars in Kozmo.com. The investment will allow Amazon to ship products such as books and compact discs in one hour to residents living in select cities, such as New York and San Francisco. Joe Galli, president and chief operating officer of Amazon reports:

Kozmo.com has developed a strong track record for meeting a unique customer need, and this agreement provides us a one-hour delivery option for the types of products that customers may want immediately.

Jan 2001

Forecasts The Great Recession

0 Comments

Celente issues a press release predicting the start of a great recession for the US and World economies.

How can anyone deny the facts proving that the scales of financial balance are so lopsided that they will not only sink the U.S. economy but also drag down the World economies with it?

Jan 2002

Gold Bull Run to begin

0 Comments

In the Winter issue of the Trends Journal, Celente, gives reasons why gold is a safer investment than world currencies.

Unlike investments made in virtual companies like e-Pets and e-Toys or real companies like Lucent or Enron, whose share prices hit the stratosphere, fell sharply or completely evaporated, gold will always be worth something

2002

FDA approves DBS

0 Comments

The Federal Food and Drug Administration approves deep brain stimulation (DBS) for Parkinson’s disease (PD). According to NIH National Institute of Neurological Disorders and Stroke:

DBS is a surgical procedure used to treat disabling motor symptoms of PD, such as tremor, rigidity, stiffness, slowed movement and walking problems. The DBS system consists of the lead, the extension, and the IPG. The lead—a thin, insulated wire also called an electrode—is inserted through a small opening in the skull and implanted in the brain. The tip of the electrode is positioned within a specific brain area. The implantable pulse generator (IPG)—similar to a heart pacemaker—delivers electrical stimulation to specific areas in the brain that control movement. Once the system is in place, electrical impulses are sent from the IPG up along the extension wire and the lead and into the brain. These impulses block abnormal electrical signals and alleviate PD motor symptoms.

13 Jun, 2003

FDA appoval

0 Comments

Novartis announces that the FDA has approved Stalevo (carbidopa, levodopa and entacapone) tablets for patients with idiopathic Parkinson’s disease (PD) who experience signs and symptoms of end-of-dose “wearing off.” Stalevo contains levodopa, the most widely used agent for Parkinson’s disease, plus carbidopa and entacapone. While carbidopa reduces the side effects of levodopa, entacapone extends its benefits, permitting Parkinson’s disease patients to have an improved ability to perform everyday tasks and a reduction in symptoms associated with the disease.

Levodopa is recognized as the cornerstone of Parkinson’s disease therapy, but its long-term use is limited by its reduced ability to fully control Parkinson’s disease symptoms. By blocking the enzymatic breakdown of levodopa, Stalevo provides more levodopa to the brain for a longer period of time. Potential patient benefits include more “on” time during which Parkinson’s symptoms are well-controlled and daily activities are improved, and simpler, more convenient dosing.

Oct 2005

Decline of US Automakers

0 Comments

Celente issues a press release stating oil and gas will skyrocket forcing auto makers to refocus their financial goals and start developing affordable energy efficient cars for US consumers.

Firmly focused on their bottom line by making big cars with big profits, US auto makers have facilitated their demise by exploiting customers wants rather than addressing both the consumer’s and society’s essential needs.

17 May, 2006

FDA approves Azilect

0 Comments

The FDA approves Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson’s disease. The drug is a monoamine oxidase type-B (MAO-B) inhibitor that blocks the breakdown of dopamine, a chemical that sends information to the parts of the brain that control movement and coordination. Dr. Steven Galson, Director of the Center for Drug Evaluation and Research, says:

This is a welcome development for the more than 50,000 Americans who are each year diagnosed with Parkinson’s disease. Parkinson’s is a relentless disease with limited treatment options, and each new therapy is an important addition to the physicians’ treatment options.

Oct 2006

Credit crisis to hit financial markets

0 Comments

Celente issues a press release stating the U.S will hit a credit crisis by the end of 2007. Millions Americans who over borrow and take credit or loans will not be able to keep paying their debt causing US financial markets to decline further.

Weighed down with massive loads of debt and locked into jobs that limit opportunities to pay it off, the paycheck to paycheck public will feel the pinch in their
pocket books and businesses will be hit hard in their bottom lines long before recession becomes “official.”

14 Nov, 2006

Announces Boost deal

0 Comments

It will allow users of the Sprint subsidiary to share location, status updates, and other information, and is aimed at young and social subscribers.

Boosts tagline asks the question Where you at? And now Loopts social mapping service can answer that question for every Boost Mobile user.

19 Mar, 2007

YouTube Awards

0 Comments

YouTube announces a feature called the YouTube Awards to recognize the best videos uploaded in 2006. Users can vote for their favorite videos and the winners will receive a trophy and recognition for their videos. Jamie Byrne, head of product marketing at YouTube, says it is unclear whether this will be an annual event or not:

We want to see how the community responds to it, but we can see this being something that grows as we continue to grow and becomes a bigger and more exciting event in the future.

9 May, 2007

Parkinson’s patch approved

0 Comments

The FDA approves Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease. Neupro patches, which are changed daily, deliver a drug called rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.